Total Payments
$1,550
2024 Payments
$339.20
Companies
10
Transactions
33
Medicare Patients
1,061
Medicare Billing
$145,809
Payment Breakdown by Category
Food & Beverage$1,101 (71.0%)
Travel$448.92 (29.0%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,101 | 31 | 71.0% |
| Travel and Lodging | $448.92 | 2 | 29.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Medtronic, Inc. | $937.17 | 13 | $0 (2023) |
| Nevro Corp. | $115.00 | 2 | $0 (2022) |
| ABBVIE INC. | $106.56 | 4 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $98.01 | 3 | $0 (2024) |
| Curonix LLC | $97.95 | 1 | $0 (2024) |
| Collegium Pharmaceutical, Inc. | $90.82 | 5 | $0 (2024) |
| Averitas Pharma Inc. | $49.80 | 2 | $0 (2024) |
| Merck Sharp & Dohme LLC | $19.37 | 1 | $0 (2024) |
| Stratus Medical, LLC | $19.00 | 1 | $0 (2023) |
| VERTEX PHARMACEUTICALS INCORPORATED | $16.71 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $339.20 | 12 | Curonix LLC ($97.95) |
| 2023 | $184.30 | 7 | AbbVie Inc. ($84.20) |
| 2022 | $460.75 | 9 | Medtronic, Inc. ($435.10) |
| 2021 | $476.79 | 4 | Medtronic, Inc. ($476.79) |
| 2020 | $89.35 | 1 | Nevro Corp. ($89.35) |
All Payment Transactions
33 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/05/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $18.53 | General |
| Category: Opioid Analgesic | ||||||
| 11/14/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $32.79 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/28/2024 | Merck Sharp & Dohme LLC | BRIDION (Drug) | Food and Beverage | In-kind items and services | $19.37 | General |
| Category: NEUROSCIENCE | ||||||
| 09/06/2024 | VERTEX PHARMACEUTICALS INCORPORATED | — | Food and Beverage | In-kind items and services | $16.71 | General |
| 08/16/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $17.59 | General |
| Category: Opioid Analgesic | ||||||
| 08/08/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $34.09 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/18/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $20.48 | General |
| Category: Opioid Analgesic | ||||||
| 06/14/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $20.41 | General |
| Category: Opioid Analgesic | ||||||
| 05/10/2024 | ABBVIE INC. | UBRELVY (Drug), BOTOX | Food and Beverage | In-kind items and services | $22.36 | General |
| Category: NEUROSCIENCE | ||||||
| 04/05/2024 | Curonix LLC | PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A (Device) | Food and Beverage | Cash or cash equivalent | $97.95 | General |
| Category: PAIN MANAGEMENT | ||||||
| 02/02/2024 | Averitas Pharma Inc. | QUTENZA (Drug) | Food and Beverage | In-kind items and services | $25.11 | General |
| Category: PAIN MANAGEMENT | ||||||
| 01/24/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $13.81 | General |
| Category: Opioid Analgesic | ||||||
| 09/12/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $31.13 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/22/2023 | Averitas Pharma Inc. | QUTENZA (Drug) | Food and Beverage | In-kind items and services | $24.69 | General |
| Category: PAIN MANAGEMENT | ||||||
| 07/26/2023 | Medtronic, Inc. | ACCURIAN (Device) | Food and Beverage | In-kind items and services | $25.28 | General |
| Category: Neuro Pain (includes Interventional) | ||||||
| 05/04/2023 | AbbVie Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $30.06 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 05/01/2023 | Stratus Medical, LLC | Nimbus (Device) | Food and Beverage | Cash or cash equivalent | $19.00 | General |
| Category: Neuro & Physical Medical Device | ||||||
| 04/07/2023 | AbbVie Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $27.30 | General |
| Category: NEUROSCIENCE | ||||||
| 03/10/2023 | AbbVie Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $26.84 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 08/17/2022 | Nevro Corp. | Omnia (Device) | Food and Beverage | In-kind items and services | $25.65 | General |
| Category: Spinal Cord Stimulator | ||||||
| 07/18/2022 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $107.55 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 07/18/2022 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $20.12 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 03/14/2022 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $22.29 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 03/07/2022 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $23.14 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 02/16/2022 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $23.89 | General |
| Category: Spinal Cord Neurostimulation | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 518 | 904 | $373,895 | $70,544 |
| 2022 | 13 | 526 | 877 | $396,450 | $73,263 |
| 2021 | 1 | 17 | 17 | $6,375 | $2,002 |
Total Patients
1,061
Total Services
1,798
Medicare Billing
$145,809
Procedure Codes
28
All Medicare Procedures & Services
28 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 144 | 371 | $74,200 | $28,611 | 38.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 88 | 88 | $33,100 | $9,237 | 27.9% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 46 | 131 | $19,650 | $8,414 | 42.8% |
| 64483 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | Facility | 2023 | 42 | 48 | $45,675 | $4,964 | 10.9% |
| 64493 | Injection of lower or sacral spine facet joint using imaging guidance, single level | Facility | 2023 | 21 | 38 | $50,320 | $4,158 | 8.3% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 37 | 37 | $14,800 | $3,930 | 26.6% |
| 64494 | Injection of lower or sacral spine facet joint using imaging guidance, second level | Facility | 2023 | 21 | 38 | $37,000 | $2,352 | 6.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 17 | 27 | $5,400 | $2,130 | 39.4% |
| 62323 | Injection of substance into lower spine canal using imaging guidance | Facility | 2023 | 20 | 26 | $29,900 | $1,866 | 6.2% |
| 27096 | Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | Facility | 2023 | 18 | 20 | $21,000 | $1,625 | 7.7% |
| 20610 | Aspiration and/or injection of fluid from large joint | Facility | 2023 | 24 | 33 | $16,750 | $1,576 | 9.4% |
| 64484 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | Facility | 2023 | 27 | 31 | $20,000 | $1,331 | 6.7% |
| 77002 | Fluoroscopic guidance for needle placement | Facility | 2023 | 13 | 16 | $6,100 | $350.88 | 5.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 106 | 283 | $56,600 | $23,171 | 40.9% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 66 | 172 | $25,800 | $10,127 | 39.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 88 | 88 | $33,000 | $9,988 | 30.3% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 41 | 42 | $16,800 | $4,792 | 28.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 38 | 51 | $10,200 | $4,104 | 40.2% |
| 62323 | Injection of substance into lower spine canal using imaging guidance | Facility | 2022 | 40 | 48 | $55,200 | $4,100 | 7.4% |
| 64493 | Injection of lower or sacral spine facet joint using imaging guidance, single level | Facility | 2022 | 19 | 32 | $41,480 | $3,569 | 8.6% |
| 64483 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | Facility | 2022 | 28 | 35 | $27,550 | $3,496 | 12.7% |
| 64635 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | Facility | 2022 | 12 | 12 | $31,680 | $2,781 | 8.8% |
| 27096 | Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | Facility | 2022 | 21 | 26 | $25,500 | $2,136 | 8.4% |
| 64494 | Injection of lower or sacral spine facet joint using imaging guidance, second level | Facility | 2022 | 19 | 32 | $30,500 | $2,052 | 6.7% |
| 64484 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | Facility | 2022 | 20 | 24 | $16,250 | $1,112 | 6.8% |
About Dr. Parth Shah, M.D
Dr. Parth Shah, M.D is a Interventional Pain Medicine healthcare provider based in Libertyville, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/10/2016. The National Provider Identifier (NPI) number assigned to this provider is 1902252810.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Parth Shah, M.D has received a total of $1,550 in payments from pharmaceutical and medical device companies, with $339.20 received in 2024. These payments were reported across 33 transactions from 10 companies. The most common payment nature is "Food and Beverage" ($1,101).
As a Medicare-enrolled provider, Shah has provided services to 1,061 Medicare beneficiaries, totaling 1,798 services with total Medicare billing of $145,809. Data is available for 3 years (2021–2023), covering 28 distinct procedure/service records.
Ad
Practice Information
- Specialty Interventional Pain Medicine
- Other Specialties Student in an Organized Health Care Education/Training Program, Pain Medicine
- Location Libertyville, IL
- Active Since 05/10/2016
- Last Updated 06/26/2024
- Taxonomy Code 208VP0014X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1902252810
Products in Payments
- INTELLIS (Device) $472.64
- INTELLIS ADAPTIVESTIM (Device) $303.56
- VANTA ADAPTIVESTIM (Device) $131.54
- PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A (Device) $97.95
- Belbuca (Drug) $90.82
- Senza Spinal Cord Stimulation System (Device) $89.35
- BOTOX (Biological) $84.20
- ENTRESTO (Drug) $66.88
- QUTENZA (Drug) $49.80
- LEQVIO (Drug) $31.13
- Omnia (Device) $25.65
- ACCURIAN (Device) $25.28
- UBRELVY (Drug) $22.36
- BRIDION (Drug) $19.37
- Nimbus (Device) $19.00
- Vanta (Device) $4.15
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.